- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ER/PR/HER2 negative
Total 15899 results
-
University of BirminghamRoche Pharma AG; Cancer Research UKActive, not recruitingBreast CancerUnited Kingdom
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast CancerUnited States
-
Public Health Institute, CaliforniaCompletedAlcohol Dependence | Problem DrinkingUnited States
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.Terminated
-
Accutar Biotechnology IncTerminatedBreast CancerUnited States
-
Ruijin HospitalRecruitingRelapsed or Refractory B-cell LymphomaChina
-
Duke UniversityGenentech, Inc.; Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
University of LiegeRecruiting
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, Italy, Spain, United Kingdom, Austria, Czechia, Hungary, Malaysia, Saudi Arabia, Taiwan, Argentina, France, Israel, Netherlands, Russian Federation, Hong Kong, Thailand, Lebanon, Bulgaria, Denmark, Po... and more
-
Joyce Marie SlingerlandStanford UniversityCompleted
-
Queen Mary University of LondonMerck Sharp & Dohme LLC; European Institute of OncologyWithdrawn
-
BiogenAcorda TherapeuticsCompleted
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
Pamela MunsterPfizer; Xynomic Pharmaceuticals, Inc.WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
-
Fuzhou General HospitalUnknownLiving-relative Kidney TransplantationChina
-
National Taiwan University HospitalUnknown
-
Vedic Lifesciences Pvt. Ltd.Completed
-
Virginia Commonwealth UniversityEli Lilly and Company; BayerTerminatedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Hospices Civils de LyonUnknown
-
PfizerRecruitingAdvanced or Metastatic Breast CancerUnited States, Taiwan, Japan, China, Canada, Korea, Republic of, Israel, Argentina, Australia, Brazil, Mexico, United Kingdom
-
Accutar Biotechnology IncRecruiting
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Recurrent Breast Cancer | ER+ Breast CancerUnited Kingdom
-
Fudan UniversityRecruitingHormone Receptor Positive HER-2 Negative Breast CancerChina
-
Haukeland University HospitalRecruitingEndometrial CancerNorway, Netherlands, Poland
-
ETOP IBCSG Partners FoundationCompleted
-
PfizerTerminatedEarly Breast Cancer (Phase 2) | Advanced Breast Cancer (Phase 1b)Spain, Sweden, Italy, Belgium
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
Tianjin Medical UniversityUnknown
-
Fondazione MichelangeloCompleted
-
Borstkanker Onderzoek GroepUMC Utrecht; Erasmus Medical Center; Servier; BOOG Study CenterActive, not recruitingBreast Neoplasm | Chemotherapy EffectNetherlands
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)Metastatic Breast CancerUnited Kingdom, Belgium, Italy
-
University Hospital, MontpellierUniversité MontpellierTerminatedBacterial Vaginosis | HPV Genital Infection (Primary Condition Studied) | Chlamydiae InfectionFrance
-
University Hospital, BrestRecruitingPulmonary Embolism | Quality of Life and DyspneaFrance
-
Qamar KhanNovartis PharmaceuticalsActive, not recruiting
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedPatients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment LinesItaly
-
Gruppo Italiano Malattie EMatologiche dell'AdultoUnknown
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative...CompletedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Stage IV Breast CancerUnited States
-
Ruijin HospitalRenJi HospitalUnknown
-
AstraZenecaCompleted
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Severance HospitalRecruitingBreast Cancer | Surgery | Recurrent Breast Cancer | Estrogen Receptor Positive Tumor | Stereotactic Body Radiotherapy | Her2-negative TumorKorea, Republic of
-
McMaster UniversityRecruiting
-
University of British ColumbiaCompletedCardiorespiratory FitnessCanada
-
Chang Gung Memorial HospitalUnknown
-
Cumberland PharmaceuticalsCompletedStaphylococcal Skin InfectionUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; North Shore...CompletedBreast CancerUnited States
-
Swiss Group for Clinical Cancer ResearchTerminated
-
GenethonActive, not recruitingLGMD2IDenmark, France, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
ReNeuron LimitedActive, not recruitingRetinitis PigmentosaUnited States, United Kingdom, Spain